GreensKeeper Asset Management, an investment management company, released its fourth quarter investor letter. A copy of the ...

Shares of Elevance Health Inc. ELV slid 1.24% to $391.22 Tuesday, on what proved to be an all-around positive trading session ...

it is easy to disregard Elevance Health (NYSE:ELV). However, stock prices are usually driven by a company’s financial performance over the long term, which in this case looks quite promising.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

With earnings season in full swing, the volume of insider transactions has fallen to seasonal lows, with only 615 transactions meeting the criteria for inclusion in Vickers Weekly Insider Report ...

Elevance Health, Inc. (NYSE:ELV – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the sixteen brokerages that are currently covering the company, Marketbeat.com reports.

Wells Fargo & Company reduced their target price on shares of Elevance Health from $593.00 to $495.00 and set an “overweight” rating on the stock in a report on Monday, November 4th.

Price Targets: Gaining insights, analysts provide estimates for the future value of Elevance Health's stock. This comparison reveals trends in analysts' expectations over time. Analyzing these ...

Elevance Health (ELV – Research Report ... Analyst Scott Fidel from Stephens downgraded the rating on the stock to a Hold and gave it a $440.00 price target. Scott Fidel has given his Hold ...

Elevance Health shares fell 21% in 2024 due to weak ... shares were added during price weakness, anticipating solid earnings growth in the future. Elevance is the largest for-profit operator ...

So it may not tell us anything about how insiders feel about the current share price. In the last year Elevance Health insiders didn't buy any company stock. You can see the insider transactions (by ...

With its stock down 7.4% over the past three months, it is easy to disregard Elevance Health (NYSE:ELV). However, stock prices are usually driven by a company’s financial performance over the long ...